HGH Systèmes Infrarouges acquired by Theon International

THEON International has entered into an exclusive agreement to acquire HGH Systèmes Infrarouges from Carlyle, covering the entirety of the company's share capital. This strategic move aims to bolster the group's capabilities in electro-optic and infrared systems, particularly for multi-domain defense applications. The transaction would integrate HGH's infrared technologies and detection solutions into THEON's portfolio, with a focus on long-range surveillance systems and automated threat detection capabilities. The acquisition leverages proprietary technologies combining sensors, software, and artificial intelligence, which are utilized in applications such as air defense, anti-drone systems, and the protection of critical infrastructure. The deal is structured with a bridge facility financing arrangement, intended to be refinanced at a later stage. This acquisition is part of a broader industrial integration strategy, aiming to create a leading European platform in defense optronics technologies. The transaction is expected to generate significant operational and commercial synergies, while accelerating the expanded group's international presence and strengthening its position in the rapidly growing defense markets.

In the past, HGH Systèmes Infrarouges was acquired by The Carlyle Group in 2018 as part of its expansion strategy.